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Abstract The catecholamine biosynthetic pathway
consists of several enzymatic steps in series, beginning
with the amino acids phenylalanine and tyrosine, and even-
tuating in the catecholamines norepinephrine (noradrena-
line) and epinephrine (adrenaline). Since the enzyme
tyrosine hydroxylase (TH; tyrosine 3-mono-oxygenase; EC
1.14.16.2; chromosome 11p15.5) is generally considered to
be rate-limiting in this pathway, probed as to whether com-
mon genetic variation at the TH gene occurred, and whether
such variants contributed to inter-individual alterations in
autonomic function, either biochemical or physiological. We
began with sequencing a tetranucleotide (TCAT) repeat in
the first intron, and found that the two most common ver-
sions, (TCAT)6 and (TCAT)10i, predicted heritable auto-
nomic traits in twin pairs. We then conducted systematic
polymorphism discovery across the *8 kbp locus, and
discovered numerous variants, principally non-coding.
The proximal promoter block contained four common vari-
ants, and its haplotypes and SNPs (especially C-824T,
rs10770141) predicted catecholamine secretion, environ-
mental stress-induced BP increments, and hypertension.
Finally, we found that two of the common promoter variants,
C-824T (rs10770141) and A-581G (rs10770140), were
functional in that they differentially affected transcriptional
activity of the isolated promoter, disrupted recognition
motifs for specific transcription factor binding, altered the
promoter responses to the co-transfected (exogenous) fac-
tors, and bound the endogenous factors in the chromatin
fraction of the nucleus. We concluded that common variation
in the proximal TH promoter is functional, giving rise to
changes in autonomic function and consequently cardio-
vascular risk.
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Abbreviations
PC12 Rat pheochromocytoma cell line
TH Tyrosine hydroxylase (tyrosine 3-mono-
oxygenase;EC 1.14.16.2)
TCAT Tetranucleotide repeat in TH intron-A
Introduction
Tyrosine hydroxylase (TH; tyrosine 3-mono-oxygenase; EC
1.14.16.2; chromosome 11p15.5), which catalyzes the for-
mation of DOPA from dopamine, is generally considered to
be the rate-limiting enzyme in the catecholamine biosyn-
thetic pathway (Flatmark and Stevens 1999). The human TH
locus, on chromosome 11p15 (Chitbangonsyn et al. 2003),
contains 13 exons/12 introns spanning approximately 8 kbp.
Although a single-copy gene, TH produces four different
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types of mRNA through alternative splicing of a single
primary transcript (Grima et al. 1987), indicating one novel
level of regulating catecholamines. Substantial loss of TH
enzymatic activity has profound consequences both in
humans (Flatmark and Stevens 1999) and in mice with tar-
geted ablation of the TH locus (Zhou et al. 1995).
TH Microsatellite Polymorphism and Hypertension
Essential (idiopathic) hypertension develops over several
decades of life. The human TH locus bears several examples
of common natural allelic variation, such as the tetranucle-
otide repeat [or microsatellite polymorphism, (TCAT)n] in
its first intron, which associate with essential hypertension
(Sharma et al., 1998). The TH tetranucleotide repeat
(TCAT)n occurs in 5–11 head-to-tail copies. Barbeau et al.
(2003) found that (TCAT)6 and (TCAT)10i alleles seemed to
be cardioprotective by association with attenuation of the
hemodynamic response to stress with increasing age, while
(TCAT)7 seemed to be deleterious by their association with
higher resting systolic blood pressure and greater hemody-
namic response to stress with increasing body mass index.
Sharma et al. (1998) found that the (TCAT)10 (‘‘E’’) allele
was over-represented in hypertensive subjects, whereas the
(TCAT)9 (‘‘D’’) allele frequency was increased in control
(normotensive) subjects. Wei et al. (1997) found (TCAT)9 to
be associated with higher norepinephrine levels.
In order to probe the role of TH polymorphism in stress-
induced disease pathways, we used a classical human twin
study design (Boomsma et al. 2002). Exploring the effects
of particular (TCAT)n alleles on ‘‘intermediate pheno-
types,’’ we stratified each individual on the basis of number
of copies of the allele. We found that the two most com-
mon alleles, (TCAT)6 and (TCAT)10i, influenced a number
of autonomic traits, both biochemical and physiological:
(TCAT)6 copy number affected basal pulse interval and
heart rate, and post-stress heart rate. (TCAT)10i copy
number affected basal pulse interval, plasma epinephrine,
and renal norepinephrine excretion (Zhang et al. 2004). We
documented the heritability of blood pressure, and found
that (TCAT)6 allele frequencies differed among individuals
stratified by genetic risk (family history) of hypertension:
in particular, family history-positive individuals were less
likely to bear the (TCAT)6 allele. Since increasing
(TCAT)6 allele copy number was associated with lower
basal and stress-induced heart rates, the results obtained
suggested a mechanism whereby (TCAT)6 alleles may be
protective against the future development of hypertension.
The (TCAT)n motif can bind such transcription factors
as AP110 or ZNF191 (Albanese et al. 2001) and may
function as a transcriptional enhancer when tested in
transfected/expressed promoter/reporter plasmids. However,
in transfected TH promoter/intron/reporter studies (Albanese
et al. 2001), the (TCAT)n repeat silences transcription in a
copy number-dependent way; by contrast, in vivo we
observed directionally opposite associations of common
(TCAT)n alleles with autonomic function: (TCAT)10i with
activation and (TCAT)6 with diminution of sympathetic
outflow (Zhang et al. 2004). Thus, transcriptional effects of
the (TCAT)n could not mechanistically explain common
variation in human autonomic function. Therefore, we
carried out systematic polymorphism discovery at the locus.
Discovery of Common TH Variants Governing
Transcription, Human Autonomic Activity and Blood
Pressure In Vivo
In order to probe the possible underlying impact of
TH variation on stress-induced disease pathways, we
re-sequenced *1.2 kbp of 50 promoter as well as all 13
exons and adjacent intronic regions for rare and common
variants in 80 ethnically diverse subjects as well as 422
twins. Plasma and urine catecholamines were measured by
radioenzymatic assay (Kennedy and Ziegler 1990).
In the coding region, we found two common bi-allelic
variants, only one of which was non-synonymous: Val81-
Met (at 37.4%) which did not associate with the autonomic
traits we studied. We also found 12 unusual coding region
variants, but the non-synonymous variants had minor allele
frequencies of only 0.3–0.6%, not sufficient to account for
the common population associations.
Thus, we turned to potential regulatory (non-coding)
variants and found 10 SNPs in the proximal promoter region,
four of which (C-824T, G-801C, A-581G, and G-494A)
were common (minor allele frequencies [10%). Statisti-
cally, C-824T (rs10770141) and A-581G (rs10770140)
seemed to influence both catecholamine secretion and the
blood pressure response to environmental stress. A multi-
variable analysis further indicated that C-824T became the
most significant predictor of change in DBP during cold
stress. The -824T allele is associated with increased cate-
cholamine production, increased blood pressure increments
in response to stress, and extreme blood pressure values in
the population. It was tempting to speculate that the func-
tional variation that we observed in -824T carriers could be
the outcome of environmental selective pressures on alleles
augmenting catecholaminergic function (Rao et al. 2007).
Mechanistic Studies of Human TH Promoter Genetic
Variation
More recently, we performed additional studies to test
whether such TH promoter variants were by themselves
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functional (Zhang et al. 2010). First, common haplotypes
(at least 1–5% frequency) of the TH promoter were gen-
erated by site-directed mutagenesis, then verified by
sequencing, and inserted into luciferase reporter vectors.
After transfection into PC12 cells, such human TH pro-
moter haplotypes showed substantial differences in lucif-
erase reporter activity. By two-way ANOVA on luciferase
activity, two of the four common variants (C-824T
[rs10770141] and A-581G [rs10770140]) altered tran-
scriptional activity. Comparison of these in cells results
with the effects of the same 4 variants in vivo indicates that
the same variants (C-824T and A-581G) that exert the
greatest effect on TH transcription in cells also have the
most pronounced effect on human catecholamine secretion
in vivo. In addition, the -824T allele displayed an aug-
mented response to typical chromaffin cell secretory
stimuli, such as nicotine or PACAP. Under basal circum-
stances, greater activity of the T allele was observed, and
when stimulated by nicotine, C-824T responded differen-
tially, with an increased effect of the drug on the T allele;
when stimulated by PACAP, the increased response of the
T allele was even more apparent. The -581G allele also
responded differentially to PACAP. In the basal state,
greater activity of the G allele was apparent; during nico-
tine stimulation, greater activity of the G allele was noted,
as was the case during response to PACAP. We further
probed the functional significance of C-824T and A-581G
by co-transfection of sequence-predicted trans-activating
factors in cells: MEF2, SRY, and FOXD1 differentially
activated C-824T, whereas the G/C-rich binding factors
SP1, AP2, and EGR1 differentially activated A-581G. At
C-824T, the co-transfected human MEF2 increased TH
promoter expression to 131.3% on the T allele, but had
little effect on the C allele. The MEF2 dominant-negative
mutant mMEF2 decreased TH promoter expression down
to 71.3% on the T allele, but had little effect on the C
allele. Thus, at C-824T, factor MEF2 acted in a direc-
tionally coordinate fashion (at T [ C) to explain the in
vivo trait associations, whereas at A-581G, factors SP1,
AP2, and EGR1 displayed similar differential actions (at
G [ A). Chromatin immunoprecipitation (ChIP) confirmed
the interaction of the endogenous transcription factors with
these motifs in the nucleus (Zhang et al. 2010).
Conclusions
We conclude that inter-individual variability in catechol-
amine secretion is controlled in substantial part by genetic
variation in the adrenergic pathway encoding cate
cholamine synthesis, especially at the classical rate-
limiting step, TH. TH promoter common polymorphisms
C-824T and A-581G are not only statistical predictors of
catecholamine secretory and stress BP response traits in
vivo, but also causally responsible for alterations in tran-
scriptional efficiency of the TH gene. Our results thus
document novel pathophysiological links between a key
adrenergic locus, catecholamine metabolism, and blood
pressure, and suggest new strategies to approach the
mechanism, diagnosis, and treatment of autonomic dys-
function as well as systemic hypertension.
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